Naperville, IL -- (SBWIRE) -- 06/05/2012 -- The present Competitive Intelligence report about Cancer Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic vaccines against cancer. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
Projects are listed according to their main antigenic constituents: peptides, recombinant proteins, antibody, DNA (plasmid, expression vector), RNA, virus-like particles (VLP), dendritic cells, tumor cells (tumor cell lines) and others.
The report includes a compilation of currently active projects in research and development for prophylaxis and therapy of cancer. In addition, the report lists company-specific R&D pipelines of cancer vaccines. Competitor projects are listed in a tabular format providing information on:
Target / Mechanism of Action,
Class of Compound,
R&D Stage and
additional comments with a hyperlink leading to the source of information.
To view the detailed table of contents for this report please visit: http://www.reportstack.com/product/79163/competitor-analysis-cancer-vaccines-.html